Der er ikke foretaget studier for at undersøge bevacizumabs farmakokinetik hos patienter med nedsat nyrefunktion, idet metabolismen og udskillelsen af bevacizumab i det væsentlige ikke finder sted i nyrerne.
No studies have been conducted to investigate the pharmacokinetics of bevacizumab in renally impaired patients since the kidneys are not a major organ for bevacizumab metabolism or excretion.